vs
Alpha Cognition Inc.（ACOG）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是Alpha Cognition Inc.的70.9倍（$197.9M vs $2.8M）。REPLIGEN CORP净利率更高（6.7% vs -245.5%，领先252.2%）。REPLIGEN CORP自由现金流更多（$17.6M vs $-7.1M）
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
ACOG vs RGEN — 直观对比
营收规模更大
RGEN
是对方的70.9倍
$2.8M
净利率更高
RGEN
高出252.2%
-245.5%
自由现金流更多
RGEN
多$24.6M
$-7.1M
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $2.8M | $197.9M |
| 净利润 | $-6.9M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | -283.7% | 9.0% |
| 净利率 | -245.5% | 6.7% |
| 营收同比 | — | 13.6% |
| 净利润同比 | — | 143.9% |
| 每股收益（稀释后） | $-0.10 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACOGRGEN
| Q4 25 | $2.8M | $197.9M | ||
| Q3 25 | $2.8M | $188.8M | ||
| Q2 25 | $1.7M | $182.4M | ||
| Q1 25 | $2.9M | $169.2M | ||
| Q4 24 | — | $174.1M | ||
| Q3 24 | — | $154.9M | ||
| Q2 24 | — | $154.1M | ||
| Q1 24 | — | $151.3M |
净利润ACOGRGEN
| Q4 25 | $-6.9M | $13.3M | ||
| Q3 25 | $-1.3M | $14.9M | ||
| Q2 25 | $-10.5M | $14.9M | ||
| Q1 25 | $-2.0M | $5.8M | ||
| Q4 24 | — | $-30.3M | ||
| Q3 24 | — | $-654.0K | ||
| Q2 24 | — | $3.3M | ||
| Q1 24 | — | $2.1M |
毛利率ACOGRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | 96.7% | 50.0% | ||
| Q1 25 | 99.6% | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率ACOGRGEN
| Q4 25 | -283.7% | 9.0% | ||
| Q3 25 | -187.0% | 8.9% | ||
| Q2 25 | -346.1% | 7.6% | ||
| Q1 25 | -125.9% | 3.9% | ||
| Q4 24 | — | -17.7% | ||
| Q3 24 | — | -5.1% | ||
| Q2 24 | — | 1.0% | ||
| Q1 24 | — | 1.3% |
净利率ACOGRGEN
| Q4 25 | -245.5% | 6.7% | ||
| Q3 25 | -46.4% | 7.9% | ||
| Q2 25 | -632.7% | 8.2% | ||
| Q1 25 | -68.5% | 3.4% | ||
| Q4 24 | — | -17.4% | ||
| Q3 24 | — | -0.4% | ||
| Q2 24 | — | 2.2% | ||
| Q1 24 | — | 1.4% |
每股收益（稀释后）ACOGRGEN
| Q4 25 | $-0.10 | $0.24 | ||
| Q3 25 | $-0.30 | $0.26 | ||
| Q2 25 | $-0.65 | $0.26 | ||
| Q1 25 | $-0.13 | $0.10 | ||
| Q4 24 | — | $-0.55 | ||
| Q3 24 | — | $-0.01 | ||
| Q2 24 | — | $0.06 | ||
| Q1 24 | — | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $66.0M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $62.5M | $2.1B |
| 总资产 | $79.7M | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资ACOGRGEN
| Q4 25 | $66.0M | $767.6M | ||
| Q3 25 | $35.4M | $748.7M | ||
| Q2 25 | $39.4M | $708.9M | ||
| Q1 25 | $45.5M | $697.2M | ||
| Q4 24 | — | $757.4M | ||
| Q3 24 | — | $784.0M | ||
| Q2 24 | — | $809.1M | ||
| Q1 24 | — | $780.6M |
总债务ACOGRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ACOGRGEN
| Q4 25 | $62.5M | $2.1B | ||
| Q3 25 | $33.9M | $2.1B | ||
| Q2 25 | $31.9M | $2.1B | ||
| Q1 25 | $40.8M | $2.0B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | — | $2.0B | ||
| Q1 24 | — | $2.0B |
总资产ACOGRGEN
| Q4 25 | $79.7M | $2.9B | ||
| Q3 25 | $46.3M | $2.9B | ||
| Q2 25 | $45.1M | $2.9B | ||
| Q1 25 | $48.6M | $2.9B | ||
| Q4 24 | — | $2.8B | ||
| Q3 24 | — | $2.8B | ||
| Q2 24 | — | $2.9B | ||
| Q1 24 | — | $2.8B |
负债/权益比ACOGRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.9M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $-7.1M | $17.6M |
| 自由现金流率自由现金流/营收 | -252.6% | 8.9% |
| 资本支出强度资本支出/营收 | 5.3% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $-20.7M | $93.9M |
8季度趋势，按日历期对齐
经营现金流ACOGRGEN
| Q4 25 | $-6.9M | $25.7M | ||
| Q3 25 | $-5.3M | $48.1M | ||
| Q2 25 | $-6.1M | $28.6M | ||
| Q1 25 | $-2.0M | $15.0M | ||
| Q4 24 | — | $39.2M | ||
| Q3 24 | — | $49.3M | ||
| Q2 24 | — | $42.2M | ||
| Q1 24 | — | $44.7M |
自由现金流ACOGRGEN
| Q4 25 | $-7.1M | $17.6M | ||
| Q3 25 | $-5.4M | $43.4M | ||
| Q2 25 | $-6.1M | $21.5M | ||
| Q1 25 | $-2.1M | $11.4M | ||
| Q4 24 | — | $33.6M | ||
| Q3 24 | — | $42.3M | ||
| Q2 24 | — | $37.4M | ||
| Q1 24 | — | $36.4M |
自由现金流率ACOGRGEN
| Q4 25 | -252.6% | 8.9% | ||
| Q3 25 | -188.8% | 23.0% | ||
| Q2 25 | -370.9% | 11.8% | ||
| Q1 25 | -72.0% | 6.8% | ||
| Q4 24 | — | 19.3% | ||
| Q3 24 | — | 27.3% | ||
| Q2 24 | — | 24.3% | ||
| Q1 24 | — | 24.0% |
资本支出强度ACOGRGEN
| Q4 25 | 5.3% | 4.1% | ||
| Q3 25 | 2.6% | 2.5% | ||
| Q2 25 | 0.5% | 3.9% | ||
| Q1 25 | 2.2% | 2.1% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | — | 5.5% |
现金转化率ACOGRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
